|
1 |
Fundamente der Mathematik / 5
2025, 1. Auflage
|
|
|
2 |
Erratum: S3-Leitlinie Exokrines Pankreaskarzinom
Enthalten in Zeitschrift für Gastroenterologie Bd. 63, 2025, Nr. 07: 783-783
|
|
|
|
3 |
Erratum: S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1
Enthalten in Zeitschrift für Gastroenterologie Bd. 63, 2025, Nr. 07: 783-783
|
|
|
|
4 |
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report
Enthalten in Oncology research and treatment Bd. 48, 2025, Nr. 9: 548-554. 6 S.
|
|
|
|
5 |
Die randomisierte, offene Phase-III-Studie FIRE-11
Enthalten in Forum 6.8.2025: 1-4
|
|
|
|
6 |
Durvalumab plus Gemcitabin-Cisplatin
Stuttgart : Thieme, 2024
|
|
|
7 |
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in \(\it BRAF}\) V600E mutated colorectal cancer
Klein-Scory, Susanne. - Bochum : Ruhr-Universität Bochum, 2024
|
|
|
|
8 |
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial
Zhang, Danmei. - Freiburg : Universität, 2024
|
|
|
|
9 |
S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1
Enthalten in Zeitschrift für Gastroenterologie Bd. 62, 2024, Nr. 10: 1724-1785
|
|
|
|
10 |
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer
Enthalten in Oncology research and treatment Bd. 47, 2024, Nr. 12: 610-615. 5 S.
|
|
Administration
